Global Aminoglycosides Antibiotics Competitive Landscape Professional Research Report 2024

Research Summary

Aminoglycosides are a class of antibiotics that are primarily used to treat bacterial infections. They work by breaking down bacterial cell walls and preventing the bacteria from replicating. Aminoglycosides are typically administered intravenously and can be used to treat a wide range of infections, including those caused by gram-negative bacteria and tuberculosis. Some common examples of aminoglycoside antibiotics include gentamicin, amikacin, and tobramycin. However, the use of aminoglycosides is associated with potential side effects, including damage to the kidneys and inner ear, and they should only be used under the guidance of a healthcare professional.

According to DIResearch's in-depth investigation and research, the global Aminoglycosides Antibiotics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Aminoglycosides Antibiotics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Aminoglycosides Antibiotics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Aminoglycosides Antibiotics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Aminoglycosides Antibiotics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Aminoglycosides Antibiotics Include:

Jemicare

Teva

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla

Pfizer

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

Aminoglycosides Antibiotics Product Segment Include:

Neomycin

Tobramycin

Gentamicin

Amikacin

Etimicin

Others

Aminoglycosides Antibiotics Product Application Include:

Hospital

Clinic

Post Care Facility

Government & Military

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Aminoglycosides Antibiotics Industry PESTEL Analysis

Chapter 3: Global Aminoglycosides Antibiotics Industry Porter's Five Forces Analysis

Chapter 4: Global Aminoglycosides Antibiotics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Aminoglycosides Antibiotics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Aminoglycosides Antibiotics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Aminoglycosides Antibiotics Market Overview

1.1 Product Definition and Statistical Scope

1.2 Aminoglycosides Antibiotics Product by Type

1.2.1 Global Aminoglycosides Antibiotics Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Neomycin

1.2.3 Tobramycin

1.2.4 Gentamicin

1.2.5 Amikacin

1.2.6 Etimicin

1.2.7 Others

1.3 Aminoglycosides Antibiotics Product by Application

1.3.1 Global Aminoglycosides Antibiotics Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Post Care Facility

1.3.5 Government & Military

1.3.6 Others

1.4 Global Aminoglycosides Antibiotics Market Revenue Analysis (2019-2030)

1.5 Aminoglycosides Antibiotics Market Development Status and Trends

1.5.1 Aminoglycosides Antibiotics Industry Development Status Analysis

1.5.2 Aminoglycosides Antibiotics Industry Development Trends Analysis

2 Aminoglycosides Antibiotics Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Aminoglycosides Antibiotics Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Aminoglycosides Antibiotics Market Analysis by Regions

4.1 Aminoglycosides Antibiotics Overall Market: 2023 VS 2024 VS 2030

4.2 Global Aminoglycosides Antibiotics Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Aminoglycosides Antibiotics Revenue and Market Share by Region (2019-2024)

4.2.2 Global Aminoglycosides Antibiotics Revenue Forecast by Region (2025-2030)

5 Global Aminoglycosides Antibiotics Market Size by Type and Application

5.1 Global Aminoglycosides Antibiotics Market Size by Type

5.2 Global Aminoglycosides Antibiotics Market Size by Application

6 North America

6.1 North America Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Aminoglycosides Antibiotics Market Size by Type

6.4 North America Aminoglycosides Antibiotics Market Size by Application

6.5 North America Aminoglycosides Antibiotics Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Aminoglycosides Antibiotics Market Size by Type

7.4 Europe Aminoglycosides Antibiotics Market Size by Application

7.5 Europe Aminoglycosides Antibiotics Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Aminoglycosides Antibiotics Market Size by Type

8.4 China Aminoglycosides Antibiotics Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Aminoglycosides Antibiotics Market Size by Type

9.4 APAC (excl. China) Aminoglycosides Antibiotics Market Size by Application

9.5 APAC (excl. China) Aminoglycosides Antibiotics Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Aminoglycosides Antibiotics Market Size by Type

10.4 Latin America Aminoglycosides Antibiotics Market Size by Application

10.5 Latin America Aminoglycosides Antibiotics Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Aminoglycosides Antibiotics Market Size by Type

11.4 Middle East & Africa Aminoglycosides Antibiotics Market Size by Application

11.5 Middle East & Africa Aminoglycosides Antibiotics Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Aminoglycosides Antibiotics Market Revenue by Key Manufacturers (2020-2024)

12.2 Aminoglycosides Antibiotics Competitive Landscape Analysis and Market Dynamic

12.2.1 Aminoglycosides Antibiotics Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Jemicare

13.1.1 Jemicare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Jemicare Aminoglycosides Antibiotics Product Portfolio

13.1.3 Jemicare Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Teva

13.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Teva Aminoglycosides Antibiotics Product Portfolio

13.2.3 Teva Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Novartis

13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Novartis Aminoglycosides Antibiotics Product Portfolio

13.3.3 Novartis Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Fangyuan-pharma

13.4.1 Fangyuan-pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio

13.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Aike Pharmaceutical

13.5.1 Aike Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio

13.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Cipla

13.6.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Cipla Aminoglycosides Antibiotics Product Portfolio

13.6.3 Cipla Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Pfizer

13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Pfizer Aminoglycosides Antibiotics Product Portfolio

13.7.3 Pfizer Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Fresenius Kabi

13.8.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio

13.8.3 Fresenius Kabi Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Sun Pharma

13.9.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Sun Pharma Aminoglycosides Antibiotics Product Portfolio

13.9.3 Sun Pharma Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Hikma

13.10.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Hikma Aminoglycosides Antibiotics Product Portfolio

13.10.3 Hikma Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Lannett Company

13.11.1 Lannett Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Lannett Company Aminoglycosides Antibiotics Product Portfolio

13.11.3 Lannett Company Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Aminoglycosides Antibiotics Industry Chain Analysis

14.2 Aminoglycosides Antibiotics Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Aminoglycosides Antibiotics Typical Downstream Customers

14.4 Aminoglycosides Antibiotics Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support